GemPharmatech Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GemPharmatech's estimated annual revenue is currently $18.8M per year.(i)
  • GemPharmatech's estimated revenue per employee is $155,000

Employee Data

  • GemPharmatech has 121 Employees.(i)
  • GemPharmatech grew their employee count by 26% last year.

GemPharmatech's People

NameTitleEmail/Phone
1
Group Treasury Director & US Chief Financial OfficerReveal Email/Phone
2
Group Chief Financial OfficerReveal Email/Phone
3
Head Immuno-Oncology TeamReveal Email/Phone
4
Business Development and Academic Sales ManagerReveal Email/Phone
5
Regional Sales & Business Development Manager, Southern CaliforniaReveal Email/Phone
6
Operations ManagerReveal Email/Phone
7
Regional Sales & Business Development ManagerReveal Email/Phone
8
BD ManagerReveal Email/Phone
9
Accounting LeadReveal Email/Phone
10
业务拓展Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is GemPharmatech?

GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.

keywords:N/A

N/A

Total Funding

121

Number of Employees

$18.8M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.2M12110%N/A
#2
$37.3M12112%N/A
#3
$21.8M12132%N/A
#4
$12.3M121-4%N/A
#5
$14.5M12161%N/A